Oliver Damm

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Health Insurance

Respiratory Syncytial Virus

Total Knee Arthroplasty

Top Venues

Infectious diseases and therapy

BMC infectious diseases

Human vaccines & immunotherapeutics

Influenza and other respiratory viruses

This page only lists publications with an associated author ORCID identifier.

Publications

Sebastian Gruhn, Manuel Batram, Moritz Wick, Edith Langevin, Stefan Michael Scholz, Wolfgang Greiner, Oliver Damm
Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany. Infectious diseases and therapy 13 (4) (2024)
Christian J A Schindler, Ian Wittenberg, Oliver Damm, Rolf Kramer, Rafael T Mikolajczyk, Tonio Schönfelder
Influenza-Associated Excess Mortality and Hospitalization in Germany from 1996 to 2018. Infectious diseases and therapy (2024)
Sebastian Gruhn, Manuel Batram, Moritz Wick, Edith Langevin, Stefan Michael Scholz, Wolfgang Greiner, Oliver Damm
Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany. Infectious diseases and therapy 13 (4) (2024)
Sebastian Gruhn, Manuel Batram, Moritz Wick, Edith Langevin, Stefan Michael Scholz, Wolfgang Greiner, Oliver Damm
Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany. Infectious diseases and therapy 13 (4) (2024)
Moritz Wick, Roman Kliemt, Anahita Poshtiban, Nils Kossack, Gerhard-Paul Diller, Samira Soudani, Mathieu Bangert, Rolf Kramer, Oliver Damm
Respiratory syncytial virus immunization patterns in Germany, 2015-2020. Human vaccines & immunotherapeutics 20 (1) (2024)
Anahita Poshtiban, Moritz Wick, Mathieu Bangert, Oliver Damm
Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review. BMC infectious diseases 24 (1) (2024)
Moritz Wick, Roman Kliemt, Anahita Poshtiban, Nils Kossack, Gerhard-Paul Diller, Samira Soudani, Mathieu Bangert, Rolf Kramer, Oliver Damm
Respiratory syncytial virus immunization patterns in Germany, 2015-2020. Human vaccines & immunotherapeutics 20 (1) (2024)
Moritz Wick, Roman Kliemt, Anahita Poshtiban, Nils Kossack, Gerhard-Paul Diller, Samira Soudani, Mathieu Bangert, Rolf Kramer, Oliver Damm
Respiratory syncytial virus immunization patterns in Germany, 2015-2020. Human vaccines & immunotherapeutics 20 (1) (2024)
Sebastian Gruhn, Manuel Batram, Moritz Wick, Edith Langevin, Stefan Michael Scholz, Wolfgang Greiner, Oliver Damm
Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany. Infectious diseases and therapy 13 (4) (2024)
Sebastian Gruhn, Manuel Batram, Moritz Wick, Edith Langevin, Stefan Michael Scholz, Wolfgang Greiner, Oliver Damm
Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany. Infectious diseases and therapy 13 (4) (2024)
Anahita Poshtiban, Moritz Wick, Mathieu Bangert, Oliver Damm
Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review. BMC infectious diseases 24 (1) (2024)
Anahita Poshtiban, Moritz Wick, Mathieu Bangert, Oliver Damm
Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review. BMC infectious diseases 24 (1) (2024)
Sebastian Gruhn, Manuel Batram, Moritz Wick, Edith Langevin, Stefan Michael Scholz, Wolfgang Greiner, Oliver Damm
Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany. Infectious diseases and therapy (2024)
Moritz Wick, Anahita Poshtiban, Rolf Kramer, Mathieu Bangert, Matthias Lange, Martin Wetzke, Oliver Damm
Inpatient burden of respiratory syncytial virus in children ≤2 years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019-2022. Influenza and other respiratory viruses 17 (11) (2023)
Oliver Damm, Anya Krefft, Jonas Ahlers, Rolf Kramer, Julian Witte, Manuel Batram, Jorg Schelling, Wolfgang Greiner
Prevalence of chronic conditions and influenza vaccination coverage rates in Germany: Results of a health insurance claims data analysis. Influenza and other respiratory viruses (2022)
Oliver Damm, Johannes Horn, Rafael T Mikolajczyk, Mirjam E E Kretzschmar, Andreas M Kaufmann, Yvonne Deleré, Bernhard Ultsch, Ole Wichmann, Alexander Krämer, Wolfgang Greiner
Cost-effectiveness of human papillomavirus vaccination in Germany. Cost effectiveness and resource allocation : C/E 15 (2017)